Clinical Trial

Extracellular Vesicles for the Treatment of Syringomyelia

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a open-label, single-arm, dose escalation phase I clinical trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of Intrathecal injection human umbilical cord-derived mesenchymal stromal cell-derived extracellular vesicle (hUC-MSC-sEV) in syringomyelia.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-01
notable Primary completion moved earlier: 2026-12-31 -> 2026-05-07 2026-07-01
Trial Details
NCT Number NCT07295067
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Yisaier Medical Technology (shan xi) Co., Ltd.
Conditions Syringomyelia
Enrollment 18 participants
Start Date 2025-12-23
Primary Completion 2026-05-07 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-30